Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Transcatheter Tricuspid Valve Replacement System
Results demonstrate a favorable safety profile and functional improvements in patients with…
New Study Reveals Organic NatureKnit Provides Greater Prebiotic Benefits Than Purified Fibers
MOMENCE, Ill., Jan. 21, 2026 /PRNewswire/ -- New research published in Frontiers in…
Study: “Reaching out” Tops the List of Most Overused Email Buzzwords
ZeroBounce analyzed more than one million real work emails to uncover the…
More than two-thirds of investment managers prominently using AI to support front office, SimCorp study reveals
Key findings: Annual survey of 200 buy-side executives shows significant increase in…
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response
• Patient 1 of Cohort 1 has now completed the 24-month follow-up…
Global study targets dengue as disease threatens nearly half the world’s population
LISMORE, Australia, Dec. 18, 2025 /PRNewswire/ -- Thousands of dengue forecasting models…
NEXTCHEM (MAIRE) AWARDED A FEASIBILITY STUDY BY RHM FOR A PMMA-POLYMER CHEMICAL RECYCLING PLANT IN GERMANY BASED ON ITS PROPRIETARY NXRe TECHNOLOGY
NEXTCHEM will develop a site-specific feasibility study for a chemical plastic recycling…
InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial
BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE:…
Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD
December 11, 2025 18:22 ET | Source: Mesoblast Limited NEW YORK, Dec.…
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a…
